Abingdon, United Kingdom

Sara Crespillo TORREÑO

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Immunocore Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sara Crespillo TORREÑO. Retrieved from https://idiyas.com/inventor/sara-crespillo-torreño

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sara Crespillo Torreño: Innovator in Hepatitis B Research

Introduction

Sara Crespillo Torreño is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) treatment. Her innovative work has led to the development of a patent that addresses critical challenges in this domain.

Latest Patents

Sara holds a patent for "Binding Molecules Specific for HBV Envelope Protein." This invention is crucial for advancing therapeutic strategies against HBV, which affects millions of people worldwide. The patent showcases her expertise and commitment to improving health outcomes through scientific innovation. She has 1 patent to her name.

Career Highlights

Sara is currently employed at Immunocore Limited, a company known for its pioneering work in immunotherapy. Her role at Immunocore allows her to collaborate with leading scientists and contribute to groundbreaking research. Her dedication to her work has positioned her as a key player in the fight against viral infections.

Collaborations

Sara has worked alongside talented colleagues, including Marcin Dembek and Andrew Knox. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Sara Crespillo Torreño exemplifies the spirit of innovation in medical research. Her contributions to the development of binding molecules for HBV highlight her commitment to improving public health. Through her work at Immunocore Limited, she continues to make strides in the fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…